Association between the hepatitis B and C viruses and metabolic diseases in patients stratified by age

Liver International

Volumn 33, Issue 8, 2013, Pages 1194-1202

  Li, Wen Cheng ^a   Lee, Yi Yen ^b,c   Chen, I Chuan ^a   Sun, Cheng ^a   Chiu, Feng Hsiang ^a   Chuang, Chung Hsun ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Hepatitis B; Hepatitis C; Insulin resistance; Lipid metabolism; Metabolic syndrome

Indexed keywords

CHOLESTEROL; GLUCOSE; HEPATITIS B SURFACE ANTIGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTICENTER STUDY; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE;

HEPATITIS B; HEPATITIS C; INSULIN RESISTANCE; LIPID METABOLISM; METABOLIC SYNDROME;

ADULT; AGE DISTRIBUTION; AGE FACTORS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; TAIWAN; URIC ACID; WAIST CIRCUMFERENCE;

EID: 84881551360     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12224     Document Type: Article

References (23)

1. Pattullo V, Heathcote J. Hepatitis C and diabetes: one treatment for two diseases? Liver Int 2010; 30: 356-64.
2. Adinolfi LE, Restivo L, Zampino R, Lonardo A, Loria P. Metabolic alterations and chronic hepatitis C: treatment strategies. Expert Opin Pharmacother 2011; 12: 2215-34.
3. Li X, Zheng Y, Liau A, et al. Hepatitis B virus infections and risk factors among the general population in nui Province, China: an epidemiological study. BMC Public Health 2012; 12: 272.
4. Watanabe S, Yaginuma R, Ikejima K, Miyazaki A. Liver diseases and metabolic syndrome. J Gastroenterol 2008; 43: 509-18.
5. Lonardo A, Loria P. The hepatitis C virus-associated dysmetabolic syndrome. Hepatology 2008; 48: 1018-9.
6. Persico M, Capasso M, Persico E, et al. Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: insulin resistance and response to antiviral therapy. Hepatology 2007; 46: 1009-15.
7. Sanyla AJ, Contos MJ, Sterling RK, et al. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome. Am J Gastroenterol 2003; 98: 2064-71.
8. Bugianesi E, Salamone F, Negro F. The interaction of metabolic factors with the HCV infection: does it matter? J Hepatol 2012; 56(Suppl. 1): S56-65.
9. Grundy SM, Cleeman JI, Daniels SR, et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-52.
10. Lao XQ, Thompson A, McHutchison JG, et al. Sex and age differences in lipid response to chronic infection with the hepatitis C virus in the United States National Health and Nutrition Examination Surveys. J Viral Hep 2011; 18: 571-9.
11. Negro F. Steatosis and insulin resistance in response to treatment of chronic hepatitis C. J Viral Hep 2012; 19(Suppl. 1): 42-7.
12. Oliviera LPM, de Jesus RP, Boulhosa R, et al. Metabolic syndrome in patients with chronic hepatitis C virus genotype 1 infection who do not have obesity or type 2 diabetes. Clinics 2012; 67: 219-23.
13. Negro F. Insulin resistance and HCV: will new knowledge modify clinical management? J Hepatol 2006; 45: 514-9.
14. Sheikh MY, CHhoi J, Qadr I, Friedman JE, Sanyal AJ. Hepatitis C virus infection: molecular pathways to metabolic syndrome. Hepatology 2008; 47: 2127-33.
15. Del Campo JA, Romero-Gómez M. Steatosis and insulin resistance in hepatitis C: a way out for the virus? World J Gastroenterol 2009; 15: 5014-9.
16. Qureshi H, Ahsan T, Mujeeb S, et al. Diabetes mellitus is equally frequent in chronic HCV and HBV infection. J Pak Med Assoc 2002; 52: 280-3.
17. Mehta SH, Brancati FL, Strathdee SA, et al. Hepatitis C virus infection and incident type 2 diabetes. Hepatology 2003; 38: 50-6.
18. Caronia S, Taylor SK, Pagliaro L, et al. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 30: 1059-63.
19. Mehta SH, Brancati FL, Sulkowski MS, et al. Prevalence of type 2 diabetes mellitus among persons with the hepatitis C virus infection in the United States. Ann Intern Med 2000; 133: 592-9.
20. Hanouneh IA, Felstein AE, Lopez R, et al. Clinical significance of metabolic syndrome in the setting of chronic hepatitis C virus infection. Clin Gastroent Hepatol 2008; 6: 584-9.
21. Persico M, Masarone M, La Mura V, et al. Clinical expression of insulin resistance in hepatitis C and B virus-related chronic hepatitis: differences and similarities. World J Gastroenterol 2009; 15: 462-6.
22. Jan CF, Chen CJ, Chiu YH, et al. A population-based study investigating the association between metabolic syndrome and hepatitis B/C infection (Keelung Community-based integrated screening study no. 10). Int J Obesity 2006; 30: 794-9.
23. Li H, Wang SX. Hepatitis C viral infection in a Chinese hemodialysis unit. Chin Med J (Engl) 2010; 123: 3574-7.